Mark A. Morgan, M.D., F.A.C.O.G., F.A.C.S., Named Chief of Gynecologic Oncology at Fox Chase Cancer Center
PHILADELPHIA (Aug. 25, 2006) — Mark A. Morgan, MD, FACOG, FACS, has been named chief of gynecologic oncology at Fox Chase Cancer Center. Morgan's clinical interests include complex gynecologic surgery and the surgical management of gynecologic malignancies, including ovarian, uterine, vulvar and cervical cancers.
Morgan has special expertise in laparoscopic surgery and fertility-sparing surgery for early cervical cancer. He also has expertise in the surgical treatment of urinary and rectal fistulas.
He came to Fox Chase's surgical oncology department from the University of Pennsylvania Health System, where he was a professor in the division of gynecologic oncology. He was also the founder and director of the division of urogynecology and female reconstructive pelvic surgery.
His teaching responsibilities at the University of Pennsylvania included supervising medical students and residents as well as clinical fellows in both gynecologic oncology and urogynecology. He also was principal investigator of the Gynecologic Oncology Group (GOG) while at Penn.
Morgan received his undergraduate degree from Rutgers College and his M.D. in 1982 from the State University of New York Downstate Medical Center, where he was elected to the medical honor society Alpha Omega Alpha. He also received the Merck Company Award for General Excellence. He completed his residency in obstetrics and gynecology and a fellowship in gynecologic oncology at the Hospital of the University of Pennsylvania.
He currently serves on the American College of Surgeons (ACOS) board of governors, the Phase I Committee of GOG and the American College of Obstetricians and Gynecologists' In-Training Examination Committee. Previous memberships on national committees include GOG's Gynecologic Oncology Committee and the ACOS Committee on Young Surgeons and Committee on Ethics.
Morgan has given many invited lectures throughout the world and published numerous research papers and book chapters. He also travels to Africa yearly on surgical missions to treat women with obstetric fistulas.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy6 Moore at 215-728-2700.